The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line  Dr. D. Mistry, Ph.D., M.G. Chambers, Ph.D.,

Slides:



Advertisements
Similar presentations
High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase  W. Ariyoshi,
Advertisements

Volume 48, Issue 6, Pages (June 2011)
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 
L. J. Sandell, Ph. D. , X. Xing, M. D. , C. Franz, M. A. , S
Inhibition of Gsk3β in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathway  R.L. Miclea, M. Siebelt, L.
Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression  T. Piepoli,
Xibin Wang, Ph. D. , Paul A. Manner, M. D. , Alan Horner, Ph. D
Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 through the inhibition of the MAPK signaling pathway.
Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways  I. Schmitz, W.
Differential effects of tumor necrosis factor-α and interleukin-1β on cell death in human articular chondrocytes  B. Caramés, Ph.D., M.J. López-Armada,
Impaired glycolytic metabolism causes chondrocyte hypertrophy-like changes via promotion of phospho-Smad1/5/8 translocation into nucleus  T. Nishida,
Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes1 1 Supported by NIH/NIAMS Program Project grant (AR-39740)
Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and.
Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner  A. Bianchi, M. Guibert, F. Cailotto,
S. Hayashi, T. Nishiyama, Y. Miura, T. Fujishiro, N. Kanzaki, S
Chondroprotective effect of the bioactive peptide prolyl-hydroxyproline in mouse articular cartilage in vitro and in vivo  S. Nakatani, H. Mano, C. Sampei,
NF-κBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes  Dr C. Lianxu, Ph.D.,
Stress-induced signaling pathways in hyalin chondrocytes: inhibition by Avocado– Soybean Unsaponifiables (ASU)  O. Gabay, B.Sc., Ph.D. fellow, M. Gosset,
Reciprocal regulation by hypoxia-inducible factor-2α and the NAMPT-NAD+-SIRT axis in articular chondrocytes is involved in osteoarthritis  H. Oh, J.-S.
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Anti-apoptotic effect of transforming growth factor-β1 on human articular chondrocytes: role of protein phosphatase 2A  M. Lires-Deán, B.S., B. Caramés,
Endoplasmic reticulum stress-induced apoptosis contributes to articular cartilage degeneration via C/EBP homologous protein  Y. Uehara, J. Hirose, S.
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic.
Chondrocyte calcium-sensing receptor expression is up-regulated in early guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression 
Chondroprotective effect of the bioactive peptide prolyl-hydroxyproline in mouse articular cartilage in vitro and in vivo  S. Nakatani, H. Mano, C. Sampei,
A.J. McGregor, B.G. Amsden, S.D. Waldman  Osteoarthritis and Cartilage 
Increase in excitatory amino acid concentration and transporters expression in osteoarthritic knees of anterior cruciate ligament transected rabbits 
Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect.
Depletion of primary cilia in articular chondrocytes results in reduced Gli3 repressor to activator ratio, increased Hedgehog signaling, and symptoms.
Angiogenesis in two animal models of osteoarthritis
Osteogenic Protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis1 1 Supported in part by NIH grants P50-AR39239,
J.A. Roman-Blas, M.D., D.G. Stokes, Ph.D., S.A. Jimenez, M.D. 
CaMKII inhibition in human primary and pluripotent stem cell-derived chondrocytes modulates effects of TGFβ and BMP through SMAD signaling  B. Saitta,
N. Brandl, A. Zemann, I. Kaupe, S. Marlovits, P. Huettinger, H
R. Sommaggio, M. Pérez-Cruz, J.L. Brokaw, R. Máñez, C. Costa 
Roles for the interleukin-4 receptor and associated JAK/STAT proteins in human articular chondrocyte mechanotransduction  S.J. Millward-Sadler, Ph.D.,
M.J. Howard, M.G. Chambers, R.M. Mason, C.M. Isacke 
Expression and regulation of Toll-like receptor 2 by IL-1β and fibronectin fragments in human articular chondrocytes  S.-L. Su, M.S., C.-D. Tsai, Ph.D.,
Cartilage-specific deletion of Alk5 gene results in a progressive osteoarthritis-like phenotype in mice  Q. Wang, Q.Y. Tan, W. Xu, H.B. Qi, D. Chen, S.
Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes  A.R. Shikhman, D.C. Brinson, J. Valbracht, M.K.
Suppression of Sestrins in aging and osteoarthritic cartilage: dysfunction of an important stress defense mechanism  T. Shen, O. Alvarez-Garcia, Y. Li,
Spontaneous osteoarthritis in Str/ort mice is unlikely due to greater vulnerability to mechanical trauma  B. Poulet, T.A.T. Westerhof, R.W. Hamilton,
Evidence for two distinct pathways in TNFα-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients 
Characterization of mature vs aged rabbit articular cartilage: analysis of cell density, apoptosis-related gene expression and mechanisms controlling.
Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-κBp65-specific siRNA  L.X. Chen, Ph.D., L. Lin,
Oxidative stress induces expression of osteoarthritis markers procollagen IIA and 3B3(−) in adult bovine articular cartilage  I.M. Khan, Ph.D., S.J. Gilbert,
Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor.
Metabolic enrichment of omega-3 polyunsaturated fatty acids does not reduce the onset of idiopathic knee osteoarthritis in mice  A. Cai, E. Hutchison,
Volume 67, Issue 1, Pages (January 2005)
Inhibition of caspase-9 reduces chondrocyte apoptosis and proteoglycan loss following mechanical trauma  C.A.M. Huser, M.Sc., M. Peacock, M.E. Davies,
Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes 
M. A. McNulty, R. F. Loeser, C. Davey, M. F. Callahan, C. M
PCB126 induces apoptosis of chondrocytes via ROS-dependent pathways
A.C. Dang, M.D., A.P. Warren, M.D., H.T. Kim, M.D., Ph.D. 
A predominantly articular cartilage-associated gene, SCRG1, is induced by glucocorticoid and stimulates chondrogenesis in vitro  Kensuke Ochi, M.D., Ph.D.,
Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression  T. Piepoli,
Implication of prostaglandin E2 in TNF-α-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs  K. Fushimi,
Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin  Y. Luan, Ph.D., M.D., L. Kong, Ph.D.,
Intra-articular injection of interleukin-4 decreases nitric oxide production by chondrocytes and ameliorates subsequent destruction of cartilage in instability-induced.
Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes 
Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation  Y. Akasaki, M.D., S. Matsuda,
Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytes  J.N.A. De Croos, Ph.D., B. Jang,
Heinz-J. Hausser, Ph.D., Ralf Decking, M.D., Rolf E. Brenner, M.D. 
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis  B.Y. Chan, E.S. Fuller, A.K. Russell, S.M. Smith, M.M. Smith,
Suppression of REDD1 in osteoarthritis cartilage, a novel mechanism for dysregulated mTOR signaling and defective autophagy  O. Alvarez-Garcia, M. Olmer,
A. Sophocleous, A.E. Börjesson, D.M. Salter, S.H. Ralston 
Y. Akasaki, A. Hasegawa, M. Saito, H. Asahara, Y. Iwamoto, M.K. Lotz 
Downregulation of inhibitor of apoptosis proteins in apoptotic human chondrocytes treated with tumor necrosis factor-alpha and actinomycin D  Dr F. Yoshimura,
IGF-1 regulation of type II collagen and MMP-13 expression in rat endplate chondrocytes via distinct signaling pathways  M. Zhang, Ph.D., Q. Zhou, M.D.,
Presentation transcript:

The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line  Dr. D. Mistry, Ph.D., M.G. Chambers, Ph.D., Dr. R.M. Mason, M.D., Ph.D.  Osteoarthritis and Cartilage  Volume 14, Issue 5, Pages 486-495 (May 2006) DOI: 10.1016/j.joca.2005.11.015 Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 1 Overview of purine metabolic pathways. Adenosine is produced from 5′AMP, either extracellularly by ecto-5′NT, or intracellularly by cytosolic-5′NT. Extracellular adenosine can signal via ARs which are coupled to G-proteins (αβγ subunits) regulating the activity of AC and the production of cAMP, or it can enter the cell via the adenosine transporter. In the cell, adenosine is metabolised to uric acid after conversion to inosine by ADA, or converted to AMP via AK. Alternatively, adenosine can be diverted into the HC pathway. High levels of adenosine can induce cell death by mechanisms dependent on either interaction with ARs or cellular uptake via the adenosine transporter, depending on the cell type (for details see the text). Figure modified from Ceruti et al.3. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 2 Histochemical detection of 5′NT activity in articular cartilage of young STR/ort and CBA mice. (A) Medial and (B) lateral tibial plateau in 6-week-old STR/ort mice. Only low levels of enzyme activity were detected, mainly in the superficial zone. The histology of the cartilage is normal. (C) A 6-week-old STR/ort medial tibial plateau. 5′NT activity was inhibited by incubating sections with the 5′NT inhibitor nickel chloride. (D) Age-matched CBA mouse medial tibial plateau showing a similar distribution of 5′NT activity. ac, articular cartilage; cc, calcified cartilage; and m, meniscus. Original magnification, ×37. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 3 Histochemical detection of 5′NT activity in articular cartilage of older STR/ort mice with OA lesions of varying severity. (A) A 20-week-old STR/ort mouse, medial tibial plateau, grade 2 OA lesion (arrow). High levels of enzyme activity are associated with chondrocytes throughout the full depth of the cartilage and are particularly prominent in the superficial and mid zones adjacent to the lesion. (B) A 40-week-old STR/ort mouse, medial tibial plateau, grade 2 lesion (arrow) showing a similar distribution and high level of 5′NT activity as in the younger mouse with a grade 2 lesion (panel A). (C) A 40-week-old STR/ort mouse, medial tibial plateau, grade 4 lesion (arrows indicate the cartilage surface at the lesion site). 5′NT activity is associated with chondrocytes throughout the full depth of the cartilage close to the lesion but is low or absent in some lacunae situated at the margins of the lesion, possibly due to chondrocyte death in this location. (D) Chondrocytes in the same medial cartilage, but located at some distance from the focal lesion area show only low levels of 5′NT activity. (E) The lateral plateaux at all ages show only modest levels of activity, mainly in the superficial zone. (F) A 20-week-old CBA mouse medial tibial cartilage. Older CBA mice show a similar distribution and level of 5′NT activity to that seen in young CBA mice. ac, articular cartilage; cc, calcified cartilage; and m, meniscus. Original magnifications, A–C, ×45; and D–F, ×40. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 4 Differential expression of AR subtype transcripts in murine chondrocytes (MC615 cells). (A) Total RNA from MC615 cells (MC) was reverse transcribed and used for PCR. The PCR products were electrophoresed on a 1.5% gel to assess comparative levels of the AR subtype expression. GAPDH was used as a loading control. Band sizes: A1, 316bp; A2a, 391bp; and A2b, 345bp. (B) Quantification of PCR bands using densitometry analysis and NIH Image software. Two further independent experiments gave very similar results. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 5 Uptake of [3H] adenosine following treatment of cells with varying concentrations of the adenosine transporter inhibitor, NBTI. Cells were pre-treated with 100μM EHNA+1.0–100μM NBTI. Adenosine uptake was assessed following addition of 10μCi [3H] adenosine in the presence of the inhibitors for 5min at 37°C. A dose responsive inhibition of uptake was observed in cells treated with 100μM NBTI. DPM, disintegrations per minute. *P=0.02, n=6 (unpaired t-test). Two further independent experiments gave very similar results. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 6 The effect of inhibitors of adenosine metabolism and HC on chondrocyte proliferation in the presence or absence of adenosine. Cells were pre-treated with 100μM EHNA, 10μM Itub, or 1mM HC, or with combinations of these, for 30min prior to incubation with medium containing the respective compound(s), with or without 5mM adenosine, for 24h. Cells treated with HC alone or with HC+ adenosine were not pretreated. Cells were trypsinised and counted. Results are shown as mean cell number×105±s.e.m., n=3wells/treatment, P values: Control vs adenosine=NS, Control vs EHNA=NS, Control vs Itub=<0.001, Control vs HC=NS, EHNA+adenosine vs EHNA=<0.001, Itub+adenosine vs Itub=NS, HC+adenosine vs HC=<0.001, Itub+HC vs HC=<0.001, EHNA+HC+adenosine vs EHNA+HC=<0.001, EHNA+HC+adenosine vs EHNA+adenosine=NS, Itub+HC+adenosine vs Itub+adenosine=<0.05, Itub+HC+adenosine vs HC or adenosine=<0.001, and Itub+HC+adenosine vs Itub+HC=NS. (ANOVA) NS=not significant. The results are representative of two further independent experiments. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 7 Conversion of procaspase-3 to caspase-3 following treatment of MC615 cells with adenosine and inhibitors of adenosine metabolism or with HC. Cells were treated for 9h at 37°C, after which they were processed for Western blot analysis for (A) procaspase-3 (33kDa) and caspase-3 (20kDa and 13kDa) and (B) PARP (33kDa). Treatments were as follows: lane 1, no treatment; lane 2, adenosine; lane 3, HC; lane 4, HC+adenosine; lane 5, EHNA; lane 6, EHNA+adenosine; lane 7, EHNA+HC; and lane 8, EHNA+HC+adenosine. The 20kDa and 13kDa cleavage products of activated caspase-3 were detected in cultures treated with HC+adenosine (lane 4), EHNA+adenosine (lane 6) and EHNA+HC+adenosine (lane 8). Proteolytic processing of PARP to an inactive 85kDa product was also detected with these treatments. The blots are representative of duplicate cultures for each condition. Two further independent experiments gave the same result. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 8 DNA laddering in cells treated with EHNA+adenosine and HC+adenosine and the effect of the caspase inhibitor, Z-VAD-FMK. Cells were treated for 9h with 5mM adenosine and 100μM EHNA or 1mM HC, in the presence or absence of the caspase inhibitor (75μM). DNA fragmentation was assessed as described in the Methods. Lane M, DNA size marker; lane 1, DNA fragment positive control supplied with kit; lane 2, untreated control; lane 3, caspase inhibitor alone; lane 4, adenosine alone; lane 5, adenosine+caspase inhibitor; lane 6, adenosine+EHNA; lane 7, adenosine+EHNA+caspase inhibitor; lane 8, EHNA alone; lane 9, adenosine+HC; lane 10, adenosine+HC+caspase inhibitor; and lane 11, HC alone. Laddering is present after treatment with either adenosine+EHNA (lane 6) or adenosine+HC (lane 9). Both effects are counteracted by co-incubation with the caspase inhibitor (lanes 7 and 10). The gel is representative of duplicate cultures for each treatment. Two further independent experiments gave the same result. Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions

Fig. 9 The effect of adenosine on chondrocytes in vivo in CBA murine knee joints. The 8-week-old disarticulated CBA knee joints were cultured in media containing 5mM adenosine in the presence or absence of 100μM EHNA. Control knee joints treated with EHNA alone show very few TUNEL positive cells (A) (×25). Co-incubation with 5mM adenosine results in a large increase in the number of TUNEL positive cells (B) (×30). Osteoarthritis and Cartilage 2006 14, 486-495DOI: (10.1016/j.joca.2005.11.015) Copyright © 2006 OsteoArthritis Research Society International Terms and Conditions